ScholarGate
Asistent

Porovnat metody

Prohlédněte si vybrané metody vedle sebe; řádky, které se liší, jsou zvýrazněny.

Rizikově upravená klinická studie fáze III×Randomizovaná klinická studie (RCT)×
OborEpidemiologieEpidemiologie
RodinaProcess / pipelineProcess / pipeline
Rok vzniku1980s–present1948 (first rigorously conducted RCT — MRC streptomycin trial)
TvůrceEvolving practice; foundational risk-adjustment principles established by Pocock (1983) and extended by numerous trialistsAustin Bradford Hill; MRC Streptomycin Trial team
TypConfirmatory randomized trial with baseline risk stratification and covariate adjustmentInterventional experimental study
Původní zdrojPocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley. ISBN: 978-0471901556Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
Další názvyrisk-stratified Phase III trial, covariate-adjusted Phase III RCT, risk-adjusted confirmatory trial, RA-Phase IIIRCT, randomized controlled trial, randomised controlled trial, clinical randomized trial
Příbuzné66
ShrnutíA risk-adjusted Phase III clinical trial is a large-scale confirmatory randomized experiment that explicitly incorporates participants' baseline prognostic risk profile into both the randomization process and the primary statistical analysis. By stratifying patients on known risk factors before allocation and adjusting for those factors in the outcome model, the design achieves greater statistical precision, reduces confounding, and produces treatment effect estimates that are more clinically meaningful across patient subgroups.A randomized clinical trial (RCT) is an experimental study design in which participants are randomly assigned to an intervention group or a control group, then followed prospectively to compare outcomes. Random allocation is the defining feature: it distributes known and unknown confounders across groups by chance, making the RCT the strongest individual study design for establishing causal efficacy of a treatment or intervention under controlled conditions.
ScholarGateDatová sada
  1. v1
  2. 2 Zdroje
  3. PUBLISHED
  1. v1
  2. 2 Zdroje
  3. PUBLISHED

Přejít na hledání Stáhnout prezentaci

ScholarGatePorovnat metody: Risk-adjusted Phase III clinical trial · Randomized clinical trial. Získáno 2026-06-20 z https://scholargate.app/cs/compare